Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us


Pharmaceutical Market in Saudi Arabia: Drugs Companies Work in Unison with NTP to Diversify Local Pharma Giants

Blog Description

At the backdrop of National Transformation Program (NTP) Vision, 2030, Saudi Arabia is set to incur magnificent reformations in its pharmaceutical space, eyeing all round excellence in drug development and delivery to ensure holistic well-being. These market highlights are in line with Market Research Reports Search Engine’s (MRRSE) recent report offering titled, ‘Pharmaceutical Market: Saudi Arabia Industry Analysis and Opportunity Assessment, 2016-2026’ pinned in its fast expanding online data archive.

Browse the full Pharmaceutical Market Report:

Under the protocol of NTP, eminent drug manufacturers in Saudi Arabia will work in unison with National Committee for Pharmaceutical Industries and Ministry of Health to achieve diverse objectives, thereby favoring ample growth towards pharmaceutical market in Saudi Arabia. Under defined reformations of NTP, local drug companies are expected to attain over 40 % shares in the domestic markets in Saudi Arabia, thereby offering stiff competition for international brands functional in Saudi Arabia.

Besides wide prevalence of chronic ailments, favorable alterations in health insurance in addition to improved healthcare infrastructure are expected to lend viable boost towards optimistic outlook of pharmaceutical market in Saudi Arabia. Besides aforementioned growth triggers, upward rise of pharmaceutical market of Saudi Arabia may also be attributed to a steadily growing population, improved mindfulness towards patented drugs, and improved spending capabilities amongst the populace. Significant rise in health insurance institutions, and strong affinity towards branded drugs and other pharmaceutical products are expected to bode well with lucrative outlook in pharmaceutical space of Saudi Arabia in the coming years. Factors as such also remain crucial in supporting cent percent FDI in pharmaceuticals. Additionally, improved distribution matrix on the back of western retail outlets supplement growth.  

Branded Drugs Estimated To Remain Most Sought After in the Coming Years

Coherent research derivatives on pharmaceutical market in Saudi Arabia documented in the report is aimed at offering report readers with workable insights on market drivers, trends, and restraints that influence growth in pharmaceutical market in Saudi Arabia. The report also examines dynamic segments which have a pronounced bearing on market growth. In terms of dynamic segmentation pharmaceutical market in Saudi Arabia is classified into product type, disease type, and distribution channel. By product type pharmaceutical market in Saudi Arabia is classified into prescription products, branded and generic drugs, and OTC products. In terms of disease type the market is diversified into cardiovascular, diabetes, cancer, obesity, infectious diseases, besides others. Pharmaceutical landscape in Saudi Arabia is further demarcated into distinct distribution channels such as hospital and retail pharmacies. Additionally, the trailing sections of the report also elaborate on competition spectrum, highlighting key participants, complete with their SWOT analysis and winning business strategies that fetch desired revenue maximization in pharmaceutical market in Saudi Arabia.